Nevala-Plagemann, Christopher http://orcid.org/0000-0003-4048-2692
Garrido-Laguna, Ignacio
Article History
First Online: 25 April 2024
Competing interests
: C.N.-P. receives institutional research funding from Theriva and has had an advisory role at Seagen. I.G.-L. receives institutional research funding from Revolution Medicine, Quanta Therapeutics, 280 Bio, Bayer, BridgeBio Pharma, Bristol–Myers Squibb, GlaxoSmithKline, Incyte, Jacobio, Lilly, MedImmune, Novartis, Pfizer, Repare Therapeutics, Sumitomo Dainippon Pharma Oncology and Tolero Pharmaceuticals; and has had consulting or advisory roles at Jazz, Kanaph, OncXer, Revolution Medicine and SOTIO.